Theravance Biopharma TBPH Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Theravance Biopharma’s reported figures.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's invested capital?
- Theravance Biopharma (TBPH) reported invested capital of $43M in Q1 2026.
- How has Theravance Biopharma's invested capital changed year-over-year?
- Theravance Biopharma's invested capital decreased by 58.5% year-over-year, from $103.53M to $43M.
- What is the long-term trend for Theravance Biopharma's invested capital?
- Over 5 years (2020 to 2025), Theravance Biopharma's invested capital has grown at a -12.2% compound annual growth rate (CAGR), from -$328.13M to $171.62M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).